The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
87 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,163,267 in first-year total cost, median $79,950.
Most frequent study sections
- Special Emphasis Panel[ZCA1 SRB-1 (M1)]7
- Special Emphasis Panel[ZCA1 SRB-P (O1)]7
- Special Emphasis Panel[ZCA1 RTRB-U (O1)]6
- Special Emphasis Panel[ZCA1 RTRB-F (M1)]5
- Special Emphasis Panel[ZCA1 RTRB-U (M1)]4
Most frequent institutions
- MASSACHUSETTS GENERAL HOSPITAL4
- BOSTON CHILDREN'S HOSPITAL3
- CASE WESTERN RESERVE UNIVERSITY3
- OHIO STATE UNIVERSITY3
- ROSWELL PARK CANCER INSTITUTE CORP3
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Consequences of HELQ alterations in alcohol and tobacco-related cancers1R03CA219434-01A1 | TAKATA, KEIICHI | UNIST | $54,000 | ZCA1 |
| 2018 | Statewide Assessment of HPV Vaccination Among Childhood Cancer Survivors1R03CA216174-01A1 | KEPKA, DEANNA LEEKIRCHHOFF, ANNE C | UNIVERSITY OF UTAH, UT | $151,979 | ZCA1 |
| 2018 | The hexosamine biosynthesis pathway in human bronchial epithelial cell transformation.1R03CA223637-01 | CHEN, WENSHU | LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE, NM | $109,000 | ZCA1 |
| 2018 | Characterizing the role of glucosamine and chondroitin supplements in the prevention of colorectal tumors1R03CA212983-01A1 | KANTOR, ELIZABETH DAVID | SLOAN-KETTERING INST CAN RESEARCH, NY | $100,965 | ZCA1 |
| 2018 | IL-15 TRiKES-based specific immunotherapy of pancreatic ductal adenocarcinoma1R03CA231766-01 | FERRONE, CRISTINA R.FERRONE, SOLDANO | MASSACHUSETTS GENERAL HOSPITAL, MA | $97,188 | ZCA1 |
| 2018 | IL-15 TRiKES-based specific immunotherapy of TNBC; resistance mechanisms1R03CA216114-01A1 | FERRONE, SOLDANOVALLERA, DANIEL A | MASSACHUSETTS GENERAL HOSPITAL, MA | $97,125 | ZCA1 |
| 2018 | Colorectal Cancer Risks in People <50 Years of Age1R03CA215775-01A1 | HAYES, RICHARD BERNARD | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $97,037 | ZCA1 |
| 2018 | Integrating Genetics of Gene Expression into Pathway Analysis for Skin SCC GWAS1R03CA219779-01A1 | HAN, JIALI | INDIANA UNIVERSITY INDIANAPOLIS, IN | $96,831 | ZCA1 |
| 2018 | Safety and anti-tumor activity of B7-H3 CAR T cells in TNBC1R03CA223886-01 | DOTTI, GIANPIETROFERRONE, SOLDANO | MASSACHUSETTS GENERAL HOSPITAL, MA | $96,719 | ZCA1 |
| 2018 | Identification of gene-gene interactions in relation to risk of esophageal adenocarcinoma and Barrett's esophagus1R03CA223731-01A1 | BUAS, MATTHEW FRANK | ROSWELL PARK CANCER INSTITUTE CORP, NY | $93,591 | ZCA1 |
| 2018 | Multi-center evaluation of digital breast tomosynthesis with synthesized two-dimensional mammography for breast cancer screening1R03CA223725-01 | CONANT, EMILYSPRAGUE, BRIAN L | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VT | $93,055 | ZCA1 |
| 2018 | A Plasmid Transfection-Based Method for the Sequential Disruption of Multiple Genes by CRISPR1R03CA223716-01 | YAN, HONG | RESEARCH INST OF FOX CHASE CAN CTR, PA | $91,500 | ZCA1 |
| 2018 | Disrupting lysosomal sequestration of sunitinib by farnesyl-transferase inhibitors as a next generation therapeutic approach for TKI resistant RCC1R03CA216173-01A1 | MAKHOV, PETR B. | RESEARCH INST OF FOX CHASE CAN CTR, PA | $91,500 | ZCA1 |
| 2018 | O-GlcNAcylation of Ewing sarcoma proteins in chromosomal maintenance1R03CA223949-01 | AZUMA, MIZUKISLAWSON, CHAD ERIC | UNIVERSITY OF KANSAS LAWRENCE, KS | $89,000 | ZCA1 |
| 2018 | CXCR3-B-mediated novel growth-inhibitory signals in breast cancer cells1R03CA215926-01A1 | PAL, SOUMITRO | BOSTON CHILDREN'S HOSPITAL, MA | $88,500 | ZCA1 |
| 2018 | c-Met-induced Renalase: a novel therapeutic target for renal cancer1R03CA219731-01A1 | BALAN, MURUGABASKAR | BOSTON CHILDREN'S HOSPITAL, MA | $88,500 | ZCA1 |
| 2018 | Preventing Secondary Skin Cancer in Young Adult Cancer Survivors1R03CA230818-01 | RECKLITIS, CHRISTOPHER JOHN | DANA-FARBER CANCER INST, MA | $88,250 | ZCA1 |
| 2018 | Genetic underpinnings of ethnic disparities in bone toxicities between Hispanic and non-Hispanic children treated for acute lymphoblastic leukemia1R03CA223730-01 | KELLY, KARA MYAO, SONGZHU, QIANQIAN | ROSWELL PARK CANCER INSTITUTE CORP, NY | $87,050 | ZCA1 |
| 2018 | Development and validation of a computational prediction model for exogenous neural stem cell migration to sites of brain tumors1R03CA216142-01A1 | GUTOVA, MARGARITAROCKNE, RUSSELL CHRISTIAN | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $86,500 | ZCA1 |
| 2018 | An ESC-GEMM platform for rapid melanoma mouse modeling1R03CA227349-01 | KARRETH, FLORIAN | H. LEE MOFFITT CANCER CTR & RES INST, FL | $86,000 | ZCA1 |
| 2018 | The role of CREB3L1 in synergy between oncolytic vaccinia virus and doxorubicin1R03CA223623-01 | KOZBOR, DANUTA B | ROSWELL PARK CANCER INSTITUTE CORP, NY | $85,900 | ZCA1 |
| 2018 | Refined genetic models of oncogenic Myc/Igh translocations in mature B cells1R03CA227343-01 | DOMINGUEZ-SOLA, DAVID | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $84,750 | ZCA1 |
| 2018 | Investigation of EDD's extraordinary tumorigenic activities1R03CA230573-01 | MA, XIAOJING | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $84,750 | ZCA1 |
| 2018 | Electronic cleansing based on effective atomic numbers in dual-energy CT colonography1R03CA223711-01 | CAI, WENLI | MASSACHUSETTS GENERAL HOSPITAL, MA | $84,250 | ZCA1 |
| 2018 | PERSONALIZED THERAPY FOR p16-DEFICIENT MELANOMA1R03CA221926-01 | GUPTA, ROMI | YALE UNIVERSITY, CT | $83,750 | ZCA1 |
| 2018 | Role of BRIT1 in telomere dysfunctional triple negative breast cancer1R03CA223612-01 | CHANG, SANDY S | YALE UNIVERSITY, CT | $83,750 | ZCA1 |
| 2018 | Porphyromonas gingivalis and Pancreatic Carcinogenesis in Mouse Models1R03CA228007-01 | GENCO, CAROLINE A | TUFTS UNIVERSITY BOSTON, MA | $81,840 | ZCA1 |
| 2018 | Genetic risk scores modeling admixture linkage disequilibrium for breast cancer in African Americans1R03CA227357-01 | GAO, GUIMINHUO, DEZHENG | UNIVERSITY OF CHICAGO, IL | $81,000 | ZCA1 |
| 2018 | Is depression associated with prostate cancer progression?1R03CA219447-01A1 | HAQUE, REINA | KAISER FOUNDATION RESEARCH INSTITUTE, CA | $80,000 | ZCA1 |
| 2018 | Characterizing a new antibody targeting growth-arrested breast cancer cells1R03CA230840-01 | HUANG, ALEX YEE-CHEN | CASE WESTERN RESERVE UNIVERSITY, OH | $80,000 | ZCA1 |
| 2018 | Dietary management of castration-resistant prostate cancer1R03CA227218-01 | MUNIRATHINAM, GNANASEKAR | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $79,950 | ZCA1 |
| 2018 | Targeting TCTP Signaling to Control Castration-Resistant Prostate Cancer1R03CA230829-01 | MUNIRATHINAM, GNANASEKAR | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $79,950 | ZCA1 |
| 2018 | Elucidating Novel Mechanisms Underlying Prostate Cancer Development1R03CA230819-01 | STOYANOVA, TANYA I | STANFORD UNIVERSITY, CA | $79,774 | ZCA1 |
| 2018 | The Genetic Architecture of Breast Parenchymal Textural Features and its Implications for Breast Cancer Risk1R03CA224196-01 | JIANG, XIA | HARVARD SCHOOL OF PUBLIC HEALTH, MA | $79,750 | ZCA1 |
| 2018 | Predicted lean body mass, fat mass, and risk of lung, pancreatic, colorectal, breast, and prostate cancers1R03CA223619-01 | GIOVANNUCCI, EDWARD | HARVARD SCHOOL OF PUBLIC HEALTH, MA | $79,750 | ZCA1 |
| 2018 | A novel regulator of triple negative breast cancer and breast cancer stem cell phenotype1R03CA223946-01 | DIMRI, MANJARI | GEORGE WASHINGTON UNIVERSITY, DC | $79,750 | ZCA1 |
| 2018 | Characterization of Ras/Akt/CFIm25/APA signaling in Glioblastoma Development and Progression1R03CA223893-01 | JI, PING | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $78,875 | ZCA1 |
| 2018 | Impact of NF-kB methylation on chemoresistance and metastasis of breast cancer1R03CA223906-01 | LU, TAONAKSHATRI, HARIKRISHNA | INDIANA UNIVERSITY INDIANAPOLIS, IN | $78,534 | ZCA1 |
| 2018 | Early Treatment Response Detection Using Highly Accurate and Reliable Breast Density Measure Derived From MRI1R03CA223052-01 | HUANG, CHUAN | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $78,365 | ZCA1 |
| 2018 | Elucidation of factors and mechanisms that promote glioblastoma stem cell motility and invasiveness1R03CA227312-01 | GALILEO, DENI S | UNIVERSITY OF DELAWARE, DE | $78,000 | ZCA1 |
| 2018 | Myeloid-derived suppressor cells in IL-27-mediated anti-tumor immunity1R03CA226806-01 | BAI, XUE-FENG | OHIO STATE UNIVERSITY, OH | $77,833 | ZCA1 |
| 2018 | Development of a Novel Genetic Assay to Study DNA Double Strand Breaks1R03CA223545-01 | PETREACA, RUBEN CIPRIAN | OHIO STATE UNIVERSITY, OH | $77,750 | ZCA1 |
| 2018 | Changing the mechanism of cancer therapeutics1R03CA229316-01 | THORBURN, ANDREW M | UNIVERSITY OF COLORADO DENVER, CO | $77,750 | ZCA1 |
| 2018 | A Novel Clinically Relevant Tumor Suppressor in Human Breast Cancer1R03CA223709-01A1 | SPINELLA, MICHAEL J | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | $77,255 | ZCA1 |
| 2018 | Normative Messages to Promote Colorectal Cancer Screening Uptake among African Americans1R03CA216011-01A1 | MANNING, MARK A | WAYNE STATE UNIVERSITY, MI | $77,000 | ZCA1 |
| 2018 | Differentiation of rhabdomyosarcoma cells by the release of paused RNA polymerase1R03CA223537-01A1 | KIKYO, NOBUAKI | UNIVERSITY OF MINNESOTA, MN | $77,000 | ZCA1 |
| 2018 | Targeting mitotic DNA synthesis for selective killing of cancer cells1R03CA227215-01 | SHIMA, NAOKO | UNIVERSITY OF MINNESOTA, MN | $76,875 | ZCA1 |
| 2018 | RNA Expression Profiling after TLR4 Inhibition in UV-induced Mouse Skin Tumors1R03CA230830-01 | DICKINSON, SALLY E | UNIVERSITY OF ARIZONA, AZ | $76,750 | ZCA1 |
| 2018 | Role of telomerase in DSB repair1R03CA223625-01 | CHAI, WEIHANG | WASHINGTON STATE UNIVERSITY, WA | $76,500 | ZCA1 |
| 2018 | Cadherin-catenin Complex and YAP1 in Prostate Cancer1R03CA230950-01 | LIN, MING-FONG | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $76,250 | ZCA1 |
| 2018 | Developing a system for PDX in vivo genetic manipulation and selection1R03CA223622-01 | PUGACHEVA, ELENA NIKOLAEVNA | WEST VIRGINIA UNIVERSITY, WV | $75,000 | ZCA1 |
| 2018 | Defining the in vivo role of Huwe1 in p53 regulation1R03CA230828-01 | KUROKAWA, MANABU | KENT STATE UNIVERSITY, OH | $75,000 | ZCA1 |
| 2018 | Prevention of colorectal cancer via targeting CYP epoxygenases1R03CA218520-01A1 | ZHANG, GUODONG | UNIVERSITY OF MASSACHUSETTS AMHERST, MA | $74,516 | ZCA1 |
| 2018 | Zinc dysregulation as a druggable target in human skin photocarcinogenesis1R03CA230949-01 | WONDRAK, GEORG T | UNIVERSITY OF ARIZONA, AZ | $73,677 | ZCA1 |
| 2018 | Eukaryotic translation factor inhibitors as selective translation factor probes and anticancer therapeutics1R03CA219320-01A1 | STEVENS, DAVID COLE | UNIVERSITY OF MISSISSIPPI, MS | $73,000 | ZCA1 |
| 2018 | Regulation of KDM4A by Lysine Methylation1R03CA223615-01A1 | JANKNECHT, RALF | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK | $72,500 | ZCA1 |
| 2018 | Functional Contribution of Metabolic Complex to Cancer Cell Metabolism1R03CA219609-01A1 | AN, SONGON | UNIVERSITY OF MARYLAND BALTIMORE COUNTY, MD | $72,194 | ZCA1 |
| 2018 | A novel approach in Basal Cell Carcinoma treatment; targeting CRD-BP1R03CA223099-01A1 | NOUBISSI, FELICITE K | JACKSON STATE UNIVERSITY, MS | $68,371 | ZCA1 |
| 2017 | The role of JMJD6 in MYC-mediated neuroblastoma1R03CA212802-01A1 | YANG, JUN | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | $89,750 | ZCA1 |
| 2017 | Statistical Analysis for Mixed Outcome Measures in Recurrent Event Studies1R03CA219450-01 | ZHU, LIANG | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $89,412 | ZCA1 |
| 2017 | Identification of susceptibility to chemotherapy induced peripheral neuropathy using patient stem cell derived sensory neurons1R03CA220219-01 | WOOLF, CLIFFORD J | BOSTON CHILDREN'S HOSPITAL, MA | $88,500 | ZCA1 |
| 2017 | A Novel Technique for Performing Simultaneous Dual Radiotracer Imaging Studies in PET1R03CA219787-01 | SCHWARTZ, JAZMIN | SLOAN-KETTERING INST CAN RESEARCH, NY | $85,950 | ZCA1 |
| 2017 | Modeling the genetic complexity of colorectal cancer in Drosophila1R03CA219321-01 | BANGI, ERDEM | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $84,750 | ZCA1 |
| 2017 | Investigate peptide-based nanofiber as a multiplexed delivery system to metastatic breast tumors1R03CA219718-01 | LAW, BENEDICT SHEK HANG | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $84,750 | ZCA1 |
| 2017 | Identification of microRNA variants associated with acute lymphoblastic leukemia1R03CA219724-01 | DEWAN, ANDREWMA, XIAOMEI | YALE UNIVERSITY, CT | $83,750 | ZCA1 |
| 2017 | Development of Near-Infrared Molecular Surgical Imaging for Sarcoma Margin Definition1R03CA219445-01 | HENDERSON, ERIC R | DARTMOUTH COLLEGE, NH | $81,000 | ZCA1 |
| 2017 | Antibodies to melanoma vaccine peptides1R03CA219715-01 | SLINGLUFF, CRAIG LEE | UNIVERSITY OF VIRGINIA, VA | $80,500 | ZCA1 |
| 2017 | Role of CRABP-II in pancreatic cancer metastasis1R03CA201738-01A1 | YU, SHUILIANGZHOU, LAN | CASE WESTERN RESERVE UNIVERSITY, OH | $80,000 | ZCA1 |
| 2017 | A Novel Mouse Model for Uterine Leiomyoma1R03CA219326-01 | WONG, KWONG KWOK | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $80,000 | ZCA1 |
| 2017 | IRF2BP2 modification by Cdk5 modulates interferon-gamma response tumor PD-L1 level1R03CA219725-01 | PETROSIUTE, AGNE | CASE WESTERN RESERVE UNIVERSITY, OH | $80,000 | ZCA1 |
| 2017 | Grail-targeting breaks the immune tolerance to melanoma1R03CA219760-01 | NURIEVA, ROZA INSAFETDINOVNA | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $80,000 | ZCA1 |
| 2017 | Overcoming EMT-driven metastatic castration-resistant prostate cancer1R03CA212890-01A1 | MUNIRATHINAM, GNANASEKAR | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $79,950 | ZCA1 |
| 2017 | SWI/SNF complex in mouse HCC development1R03CA208215-01A1 | CHEN, XIN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $79,250 | ZCA1 |
| 2017 | Exploring mechanisms to increase cancer cell antigenicity by modulating lineage-specific transcription in tumors1R03CA212987-01A1 | WIDLUND, HANS RAGNAR | BRIGHAM AND WOMEN'S HOSPITAL, MA | $78,830 | ZCA1 |
| 2017 | Targeted hyperthermia in combination with chimeric TRAIL and chemotherapeutic agent treatment for colorectal liver metastasis1R03CA212125-01A1 | LEE, YONG J | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $78,209 | ZCA1 |
| 2017 | Interleukin-37: The molecular basis of the atypical interleukin-1 family dimer1R03CA219743-01 | EISENMESSER, ELAN Z | UNIVERSITY OF COLORADO DENVER, CO | $77,750 | ZCA1 |
| 2017 | A pooled analysis of dietary long-chain omega-3 fatty acid intake and endometrial cancer risk1R03CA212808-01A1 | BRASKY, THEODORE M. | OHIO STATE UNIVERSITY, OH | $77,542 | ZCA1 |
| 2017 | Disparities in the Availability of Cancer Clinical Trials: A Multi-level Analysis1R03CA219621-01 | BANSAL, AASTHAA | UNIVERSITY OF WASHINGTON, WA | $77,521 | ZCA1 |
| 2017 | Developing targeted activatable peptides to amplify radiosensitizer delivery1R03CA219744-01 | ADVANI, SUNIL J | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $77,500 | ZCA1 |
| 2017 | Alteration of the miR-let-7c:Lin28 ratio as a predictor of therapy resistance in Prostate Cancer1R03CA198696-01A1 | NADIMINTY, NAGALAKSHMI | UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS, OH | $76,750 | ZCA1 |
| 2017 | Targeting the PTAP domain of TSG101 in ERBB2-associated mammary cancer1R03CA219332-01 | WAGNER, KAY-UWE | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $75,792 | ZCA1 |
| 2017 | The Role of the miRNA Cluster at 14q32 in Lipid Regulation and Renal Cancer Biology1R03CA212696-01A1 | NANJUNDAN, MEERA | UNIVERSITY OF SOUTH FLORIDA, FL | $74,750 | ZCA1 |
| 2017 | Novel Combinatorial Therapeutic Approach for Prostate Cancer1R03CA219336-01 | AFAQ, FARRUKH | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $74,250 | ZCA1 |
| 2017 | Atypical Chemokine Receptor 4 (ACKR4) in Anti-tumor Immunity in colorectal cancer1R03CA219129-01 | SUBRAMANIAN, SUBBAYA | UNIVERSITY OF MINNESOTA, MN | $73,092 | ZCA1 |
| 2017 | Novel Chemical Biology Probes based on Selective Inhibitors of the Polo-Box Domain of PLK11R03CA212889-01A1 | MCINNES, CAMPBELL | UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA, SC | $71,623 | ZCA1 |
| 2017 | Microbiome Dynamics During Cancer Progression1R03CA195305-01A1 | PHILLIPS, JAMES GREGORY | IOWA STATE UNIVERSITY, IA | $70,916 | ZCA1 |
| 2017 | Predicting menthol cigarette and flavored cigar smokers’ responses to menthol or flavored tobacco restrictions: results from experimental auctions1R03CA219737-01 | ROSE, SHYANIKA W | TRUTH INITIATIVE FOUNDATION, DC | $68,981 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.